New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease ...Middle East

InPedILD Phase III trial showed encouraging results for both primary endpoints. Full data were published in the European Respiratory Journal and presented at the European Respiratory Society International Congress in Barcelona, Spain If approved, nintedanib would become the first approved...

Read More Details
Finally We wish PressBee provided you with enough information of ( New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease )

Also on site :

• Apple claims San Jose engineer stole trade secrets, took them to rival
• Kendall Jenner’s Venice Getaway Post Draws Sweet Message from Kris Jenner
• EU country calls for dialogue with Russia